Search

everythinglearnresearchcommunity

for

Search:↓

Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Mycophenolate mofetil can effectively treat autoimmune hepatitis when standard drugs fail.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

Upadacitinib effectively treats skin conditions like eczema and psoriasis and is becoming more widely used and affordable.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Cyclosporine effectively treated a woman's stubborn skin condition.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

Adalimumab significantly improved Hidradenitis Suppurativa and quality of life in two patients.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

IL-17 inhibitors are more effective than methotrexate in preventing psoriatic arthritis in psoriasis patients.

Tofacitinib helped a patient regrow hair after 40 years of total hair loss.

An antibiotic called co-trimoxazole can effectively treat autoimmune diseases.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

Immunoadsorption successfully treated a man's resistant polymyositis.

Mycophenolate mofetil helped reduce steroid use in treating a dog's autoimmune skin disease.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Ixekizumab quickly and effectively clears palmoplantar psoriasis in both adults and children.

Canakinumab's effect on COVID-19 outcomes is unclear.

Upadacitinib effectively treats psoriasis and lichen planus together.

Type I interferons may help treat skin issues in lupus and dermatomyositis.